BRIVAHENZ 100

About

Brivaracetam, marketed as BRIVAHENZ, is an advanced antiepileptic drug (AED) specifically designed for the treatment of partial-onset seizures, with or without secondary generalization. It functions by selectively binding with high affinity to synaptic vesicle protein 2A (SV2A) in the brain. This binding is believed to modulate the release of neurotransmitters, thereby stabilizing hyperexcitable neurons and reducing the abnormal electrical activity that characterizes epileptic seizures. BRIVAHENZ is often utilized as an adjunctive therapy, meaning it is added to existing seizure medications, for adults and pediatric patients aged 4 years and older. Its precise mechanism of action contributes to its efficacy in controlling seizure frequency and improving the quality of life for individuals living with epilepsy. Clinical studies have demonstrated its effectiveness and generally favorable tolerability profile, making it a valuable option in epilepsy management.

Uses

• Treatment of partial-onset seizures.
• Adjunctive therapy for epilepsy.
• Management of focal seizures.
• Used in adults and children with epilepsy.

Directions For Use

Take exactly as prescribed by your doctor, usually twice daily with or without food. Do not stop taking suddenly without medical advice.

Benefits

• Reduces frequency of partial-onset seizures.
• Well-tolerated in many patients.
• Can be used as adjunctive therapy.
• Offers a targeted mechanism of action.
• Available in various formulations.
• Improves seizure control.

Side Effects

• Drowsiness
• Dizziness
• Fatigue
• Nausea
• Vomiting
• Irritability
• Headache
• Insomnia
• Constipation
• Diarrhea
• Nasopharyngitis
• Mood changes

Safety Measures

• Alcohol - Avoid alcohol as it can increase central nervous system side effects like dizziness and drowsiness.
• Pregnancy - Use only if the potential benefit outweighs the risk to the fetus; consult a doctor.
• Breastfeeding - Small amounts may pass into breast milk; consult a healthcare professional.
• Liver - Dose adjustment may be necessary in patients with hepatic impairment.
• Kidney - Generally no dose adjustment needed for mild to moderate renal impairment.
• Lung - No specific precautions for lung conditions are typically required.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.